Medical/Pharmaceuticals

Zimmer Biomet Opens ZBEdge Customer Experience Centre in Singapore to Drive Robotics and Medical Technology Transformation

SINGAPORE, Feb. 11, 2022 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), aglobal medical technology leader, today celebrated the opening of the ZBEdge Customer Experience Centre (CEC), a unique facility located at the company'sAsia Pacific regional headquarters in Singapore. ...

2022-02-11 08:00 5577

Seegene Signs Supply Deal to Deliver 4 million COVID-19 Tests to Brazil

SEOUL, South Korea, Feb. 10, 2022 /PRNewswire/ -- Seegene Inc. (KQ 096530), South Korea's leading molecular diagnostic company, today announced that it has signed a supply deal with the Ministry of Health ofBrazil to deliver four million COVID-19 tests. Since January 2022, Brazil has battled a...

2022-02-10 20:00 2175

GLOBAL HEALTH TECHNOLOGY PLATFORM, PROXIMIE, ANNOUNCES NEW SENIOR APPOINTMENTS, BUILDING ON ITS STRONG START TO 2022

General Manager for the Americas - Charles H. Wilhelm, and Chief Growth Officer -Dave Herrmann, appointed BOSTON, Feb. 10, 2022 /PRNewswire/ -- Proximie, the global health technology platform digitizing operating rooms (OR) around the world, announces the appointments of a General Manager for th...

2022-02-10 20:00 2286

GenScript Sets Up State-Of-Art Manufacturing Facility in Singapore to Strengthen Manufacturing Capability

SINGAPORE, Feb. 10, 2022 /PRNewswire/ -- GenScript Biotech Corporation (Stock Code: 1548.HK), the world's leading life science research tools and services provider, today announced the opening of more than 30,000-square-feet facility for highly automated protein and gene preparation services. The...

2022-02-10 16:34 6215

TABERNACLE HEALTH GROUP LAUNCHES CHINESE PROPRIETARY MEDICINE, AVROCIL (TM) COLD AND FLU AID

SINGAPORE, Feb. 10, 2022 /PRNewswire/ -- As we enter the cold and flu season, it can be cumbersome to fall sick when the rest of the world is celebrating the New Year. Avrocil™ – Cold & Flu Aid (Product Photos) For those who hav...

2022-02-10 15:17 2365

Well Begun AND Half Done! - SIRONA Randomized Trial Achieves fifty percent enrollment

JENA, Germany, Feb. 10, 2022 /PRNewswire/ -- Concept Medical Inc.,  focused on vascular intervention drug delivery devices, releases the second status update of SIRONA RCT (Head-to-Head Comparison ofSIROlimus versus Paclitaxel Drug-Eluting BallooN Angioplasty in ...

2022-02-10 08:21 2151

USI Awarded S&P Global Bronze Class in Sustainability Yearbook 2022

SHANGHAI, Feb. 10, 2022 /PRNewswire/ -- USI (SSE: 601231) is pleased to announce the recognition as a S&P Global Bronze Class company in our first invited participation of the S&P Global ESG Index Corporate Sustainability Assessment (CSA). The Sustainability Yearbook 2022 is based on the 2021 CSA...

2022-02-10 07:00 3055

Correction: Year-end report 2021 Bactiguard Holding AB

STOCKHOLM, Feb. 9, 2022 /PRNewswire/ -- In previous press releases regarding the year-end report for 2021, incorrect information related to "Cash flow from operating activities" has been reported. Correction is made with this press release and the correct PDF is attached for Bactiguard Holding AB...

2022-02-09 22:17 2189

X-Chem and Excelra's GOSTAR Join Forces to Advance Drug Discovery for Challenging Targets

LONDON and HYDERABAD, India, Feb. 9, 2022 /PRNewswire/ -- A new collaboration between data science and analytics leader, Excelra, and artificial intelligence pioneer X-Chem will accelerate preclinical drug discovery and aid scientists to find new drug candidates for currently hard-to-drug targets...

2022-02-09 22:00 2525

Sirtex Medical and Grand Pharmaceutical Group Limited receive NDA approval of SIR-Spheres® Y-90 resin microspheres in China from the National Medical Products Administration

SIR-Spheres® Y-90 resin microspheres are the first therapeutic radiopharmaceutical approved by the NMPA in 2022 WOBURN, Mass., Feb. 9, 2022 /PRNewswire/ -- Sirtex Medical ("Sirtex"), a leading manufacturer of targeted liver cancer therapies, announced today with its shareholder, Grand Pharmaceut...

2022-02-09 21:30 1508

Angel Yeast's Patented Probiotic S. boulardii Alleviates Common IBD Symptoms, New Research Shows

YICHANG, China, Feb. 9, 2022 /PRNewswire/ -- Angel Yeast Co., Ltd ("Angel Yeast"), a listed global yeast and yeast extract manufacturer, has partnered with the Huazhong University of Science and Technology to conduct a clinical study that investigated the relationship ...

2022-02-09 21:00 2363

Mobile Medical Imaging Systems Improving Care Accessibility and Convenience for Patients

Portability and cost-effectiveness are key factors propelling the adoption of mobile medical imaging technology globally, says Frost & Sullivan SAN ANTONIO, Feb. 9, 2022 /PRNewswire/ -- Frost & Sullivan's recent analysis finds that the drawbacks of traditional medical imaging platforms are drivin...

2022-02-09 20:00 1389

Sirnaomics Launches Phase I Clinical Trial of RNAi Therapeutic STP707 Delivered Systemically for the Treatment of Solid Tumors

HONG KONG, Feb. 9, 2022 /PRNewswire/ -- Sirnaomics Ltd. (the "Company" or "Sirnaomics", stock code: 2257.HK), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announced the start of a Phase I clinical trial for evaluation of the safety, tolerability and anti-...

2022-02-09 17:10 1757

Hummingbird Bioscience Publishes Preclinical Data Demonstrating Therapeutic Potential of HMBD-002 in VISTA-expressing Cancers

HOUSTON and SINGAPORE, Feb. 9, 2022 /PRNewswire/ -- Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets in cancer and autoimmune disease, today announced the publication of preclinical data for HMBD-002, a nov...

2022-02-09 17:00 1510

Glenmark and SaNOtize announce positive Results from Phase 3 Clinical Trial of NONS (FabiSpray®) in Non-Hospitalized Adult Indian Patients with COVID-19

* Phase 3 trial in India met the key endpoints and demonstrated reduction of viral load of 94% in 24 hours and 99% in 48 hours. * NONS was safe and well tolerated in COVID-19 patients. * Glenmark received manufacturing and marketing approval from India's drug regulator for Nitric Oxide Nasal...

2022-02-09 15:47 1975

COLOPLAST SINGAPORE LAUNCHES SENSURA MIO(R), A PRODUCT MADE WITH THE LATEST TECHNOLOGY FOR OSTOMY AND STOMA CARE

* SenSura® Mio features BodyFit technology, an elastic adhesive technology fit for all peristomal body profiles. SINGAPORE, Feb. 9, 2022 /PRNewswire/ -- Coloplast, one of the world's leading manufacturers of stoma care products launches its latest product innovation, the SenSura®Mio in Singapor...

2022-02-09 12:44 1717

Luye Pharma Grants Laboratorio LIBRA Exclusive Marketing Rights for Seroquel and Seroquel XR in Chile

SHANGHAI, Feb. 9, 2022 /PRNewswire/ -- Luye Pharma Group announced today that it has entered into an agreement with Laboratorio LIBRA, under which the company grants Laboratorio LIBRA the exclusive rights to market its innovative CNS (central nervous system) drugs Seroquel (quetiapine fumarate, i...

2022-02-09 11:57 1732

CStone announced new drug approval of China's first IDH1 inhibitor TIBSOVO® (ivosidenib tablets) as a new precision therapy for patients with acute myeloid leukemia

* TIBSOVO®, a first-in-class drug, is approved for adult patients with relapsed/refractory acute myeloid leukemia (R/R AML) who have a susceptible IDH1 mutation * Clinical study data showed that TIBSOVO® had robust clinical efficacy and a well-tolerated and manageable safety profile in Chines...

2022-02-09 11:53 3157

Bugworks Research Inc. secures US$18M Series B1 Funding from Reputed Global Investor Syndicate (The EU, UK, Japan, South Africa & India), led by Lightrock India

This Funding will advance highly differentiated assets in the dual areas of Antimicrobial Resistance (AMR) and Immuno-Oncology (IO) BANGALORE, India, SARATOGA, Calif. and ADELAIDE, Australia, Feb. 9, 2022 /PRNewswire/ -- Bugworks Research, a clinical stage multi-indication therapeutics company, ...

2022-02-09 10:00 9662

Bactiguard presents focused growth strategy and sets new long-term financial targets

STOCKHOLM, Feb. 9, 2022 /PRNewswire/ -- Bactiguard presents new long-term financial targets in connection with the year-end report for 2021. The new financial targets relate to growth and profitability, with annual revenues of at least1 billion SEK and annual EBITDA of at least 400 million SEK in...

2022-02-09 07:27 1803
1 ... 171172173174175176177 ... 382